AVR: Anteris Technologies Ltd Net earnings per share (EPS TTM)

Symbol and logo of brand anteristech.com (AVR)

Anteris Technologies Global revenue is based on the implementation of biomimetic prostheses for cardiac surgery. This 12-month net income per share chart visualizes this trajectory, where the -1.60 indicator expresses the state of the metric. The development of the DurAVR valve and expected FDA approval create growth potential. High demand from centers for the unique hemodynamics of the devices expands the company's market reach.

AVR anteristech.com Net earnings per share for the last four quarters (12/14/2024 - 11/15/2026)

Anteris Technologies Ltd (AVR) - metric breakdowns and financial figures

- current quotes and average value forecast:
Price Chart Anteris Technologies|AVR - Fair Value Consensus
- market capitalization information:
Market Capitalization Anteris Technologies Global|AVR - Company Buyout Price
- business book valuation details:
Net Assets per Single Share Anteris Technologies Global|AVR - Book Valuation of Business|Market Cap to Net Assets Ratio anteristech.com|AVR - Aggregate Asset Value
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Anteris Technologies Global|AVR - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital Anteris Technologies Ltd|AVR - Company Cumulative Debt|Debts to Book Capitalization AVR|AVR - Company Long-Term Liabilities|Company Short-Term Debts Anteris Technologies Global|Quick Liquidity anteristech.com
- earnings and multiples data:
AVR - Company Profit|Expected Profit Anteris Technologies Global|AVR - Market Cap to Earnings|Future Price to Earnings anteristech.com|AVR - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Anteris Technologies|AVR - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) Anteris Technologies Global|AVR - Net earnings per share for the trailing year|Quarterly EPS earnings growth anteristech.com|AVR - Expected net earnings per share growth this year|Earnings growth forecast for next year Anteris Technologies Global
- total revenue and sales volume data:
AVR - Company Total Revenue|Company Projected Revenue Anteris|AVR - Price-to-Revenue Coefficient|Forward Price-to-Revenue Multiple AVR|AVR - Revenue Dynamics YoY (Last Twelve Months)
Basic company analysis:Anteris Technologies Ltd (AVR)
Flagship merchandise of Anteris

This indicator measures the rolling annual profit per share, adjusted for changes in the volume of issuance, which allows for an assessment of real capital generation efficiency without accounting for equity dilution. By analyzing the current rolling annual net income per share, an investor can compare the financial stability of Anteris Technologies Global (AVR) with the commercialization potential of their unique 3D heart valve models.

Competitor analysis

Regeneron Corp - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months iRhythm Technologies Inc|LNTH: Net earnings per share (EPS TTM)|Mineralys Therapeutics Inc - Earnings per share for the trailing year|HTFL (HeartFlow Medical) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Kestra Medical|Earnings per share for the last twelve months Esperion Corp (ESPR)|AMRN (Amarin) - Earnings per share for the trailing year|Tenaya Therapeutics, Inc. - Net earnings per share for the last 12 months|CVRX - Net earnings per share for the last 12 months|Milestone Pharmaceuticals, Inc. - Net earnings per share (EPS TTM)|cardiolrx.com - Earnings per share for the last four quarters|BEAT (HeartBeam) - Net earnings per share for the last 12 months|Tenax Therapeutics, Inc. - Earnings per share for the trailing year|ADGM (Adagio Medical, Inc.) - Net earnings per share (EPS TTM)|BioCardia Inc (BCDA) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) VTAK|ABIO (ARCA Biopharma Inc) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ACST (Acasti Pharma Inc)|Earnings per share for the trailing year AVTE|VERV: Net earnings per share for the last 12 months|WINT - Net earnings per share (EPS TTM)